Table II.
Effect of subchronic exposure to SS-ZnNPs (40–60 nm) and LS- ZnNPs (80–100 nm) on glucose (GLU), glutamic pyruvic transaminase (GPT), glutamic oxaloacetic transaminase (GOT), and lactate dehydrogenase (LDH) levels in O. niloticus on days 0, 7 and 14. For given times, concentrations with different lowercase letters are significantly different (p<0.05); one-way ANOVA followed by Tukey or Kruskal Wallis post-hoc test
Group | GLU (U/L) |
GPT (U/L) |
GOT (U/L) |
LDH (U/L) |
|
---|---|---|---|---|---|
Initial | 48.0 ± 2.9 | 8.8 ± 0.2 | 53.7 ± 2.5 | 544 ± 10 | |
Control | 7th day | 48.3 ± 2.5ab | 8.8 ± 0.3 | 53.2 ± 2.1ab | 532 ± 6b |
SS-ZnNPs (1 mg/L) | 52.6 ± 2.0 ab | 9.2 ± 0.4 | 48.7 ± 1.6b | 517 ± 18b | |
SS-ZnNPs (10 mg/L) | 65.5 ± 5.0a | 9.7 ± 0.8 | 66.3 ± 3.7a | 523 ± 9b | |
LS-ZnNPs (1 mg/L) | 51.3 ± 2.4ab | 9.1 ± 0.9 | 61.9 ± 3.8ab | 550 ± 12b | |
LS-ZnNPs (10 mg/L) | 42.3 ± 1.7b | 9.6 ± 1.1 | 60.4 ± 3.7ab | 658 ± 14a | |
Control | 14th day | 47.3 ± 2.1bc | 8.6 ± 0.4ab | 70.5 ± 1.7a | 472 ± 29ab |
SS-ZnNPs (1 mg/L) | 61.1 ± 3.6ab | 9.1 ± 0.5a | 75.0 ± 2.0a | 466 ± 22ab | |
SS-ZnNPs (10 mg/L) | 69.1 ± 3.2a | 9.8 ± 0.9a | 72.0 ± 3.5a | 408 ± 18b | |
LS-ZnNPs (1 mg/L) | 34.3 ± 3.8c | 5.7 ± 0.49b | 43.1 ± 3.7b | 521 ± 23a | |
LS-ZnNPs (10 mg/L) | 52.4 ± 3.0ab | 6.9 ± 1.1ab | 47.7 ± 3.0b | 536 ± 12a |